Update on CAR T-Cell Therapies

Listen Now

Topics Covered

• Overview of CAR T-Cell Therapies, in the Context of COVID-19
• Understanding CARs - Chimeric Antigen Receptors
• When to Consider CAR T-Cell Therapies as a Treatment Choice
• Clinical Trials for CAR T-Cell Therapies
• Discussion of CAR T-Cell Therapies
• Managing Potential Treatment Side Effects
• Specific Examples of How CAR T-Cell Therapies Contributes to Oncology Care
• Key Questions to Ask Your Health Care Team about CAR T-Cell Therapies
• The Benefits of CAR T-Cell Therapies
• Follow-Up Care: What to Expect
• Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology & List of Questions
• Questions for Our Panel of Experts

Our Panel of Experts

John P. Leonard, MD

Senior Associate Dean for Innovation and Initiatives, Executive Vice Chair, Weill Department of Medicine, Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, Weill Cornell Medicine, NewYork-Presbyterian

Caron Alyce Jacobson, MD

Medical Director, Immune Effector Cell Therapy Program, Physician, Dana-Farber Cancer Institute, Assistant Professor of Medicine, Harvard Medical School

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on May 10, 2021.